Chargement en cours...
Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
The translation of cardioprotection from robust experimental evidence to beneficial clinical outcome for patients suffering acute myocardial infarction or undergoing cardiovascular surgery has been largely disappointing. The present review attempts to critically analyse the evidence for confounders...
Enregistré dans:
| Publié dans: | Br J Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680006/ https://ncbi.nlm.nih.gov/pubmed/31430831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14839 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|